Search
for
Sort by
Research 511–540 of 1000+
- Free Testosterone: Pumping up the Tires or Ending the Free Ride?
- Tissue-Selective Regulation of Androgen-Responsive Genes
- SAT645 Cardiac Autonomic Modulation In Transgender Men Under Gender-affirming Hormone Therapy
- SUN-069 A 14 Year Old Female with Primary Amenorrhea
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- COVID-19 and hypopituitarism
- High-throughput Sequencing to Identify Monogenic Etiologies in a Preselected Polycystic Ovary Syndrome Cohort
- 8483 Changes in kidney hemodynamics during gender-affirming hormone therapy in transgender individuals - findings from the KNIGHT pilot study
- MON-317 Prognostic Factors and Mortality According to the Structural and Functional Classification of Acromegaly
- MON-369 Treatment of Nonclassic 11-Hydroxylase Deficiency with "Hair, Skin, and Nails," an Over-the-Counter, Insulin Sensitizing Vitamin/Mineral Supplement
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Assessment of the Relationship Between Serum High Molecular Weight Adiponectin Hormone Levels and Insulin Resistance in Patients with Polycystic Ovary Syndrome
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Polycystic ovary syndrome: Challenges in adolescence
- High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS)
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Mood disorders and quality of life in polycystic ovary syndrome
- Cardiovascular risk factors and events in women with androgen excess
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Does a male polycystic ovarian syndrome equivalent exist?
- Cross-sex hormone therapy for gender dysphoria
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves
- Treatment of hyperandrogenism in women
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia
- Sertoli–Leydig cell tumors: hormonal profile after dynamic test with GnRH analogue: triptorelin represents a useful tool to evaluate tumoral hyperandrogenism
- Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36)